![Ozempic e Wegovy associados a uma doença rara que causa cegueira, diz estudo](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEJ4F0S7_L.jpg)
Por favor, tente outra pesquisa
Nome | Idade | Desde | Título |
---|---|---|---|
Hisashi Hieda | 87 | 2001 | Executive Managing Advisor & Director |
Kiyoshi Onoe | 89 | 2005 | Executive MD & Director |
Osamu Kanemitsu | 70 | 2019 | President, COO, Head of Corporate Planning & Director |
Yoshishige Shimatani | 72 | 2017 | Executive MD & Independent Outside Director |
Kenji Shimizu | 63 | 2019 | Executive VP & Director |
Yuzaburo Mogi | 89 | 2003 | Executive MD & Independent Outside Director |
Tomoyuki Minagawa | 60 | 2022 | Executive MD & Director |
Akira Kiyota | - | 2023 | Executive MD & Independent Outside Director |
Ryosuke Fukami | 62 | 2022 | Executive MD & Director |
Shinichiro Ito | - | 2023 | Executive MD & Independent Outside Director |
Takashi Wagai | 72 | 2021 | Executive MD & Director |
Makiko Yoshida | 64 | 2024 | Independent Outside Director |
Kiyoto Saito | 60 | 2024 | Outside Director |
Takamitsu Kumasaka | 75 | 2022 | Executive MD & Independent Outside Director |
Koichi Minato | 72 | 2022 | Executive MD & Director |
Mina Masaya | 56 | - | Executive MD & Director |
Quer mesmo bloquear %USER_NAME%?
Se o fizer, não poderá consultar as mensagens de %USER_NAME% e vice versa em Investing.com.
Adicionou %USER_NAME% com sucesso à sua Lista de Bloqueios
Uma vez que acabou de desbloquear esta pessoa, deve aguardar 48 horas antes de bloqueá-la novamente.
Diga-nos o que achou deste comentário
Obrigado!
Seu comentário foi enviado aos moderadores para revisão